Clinical trials: Pathological Gambling
Pathological Gambling
Memantine Treatment Study of Pathological Gambling
The goal of the proposed study is to evaluate the efficacy and safety of the drug memantine in individuals with pathological gambling (PG).
- Trial name
- NCT00585169
- Testing
- Memantine Hydrochloride
- Where
- 2 sites in United States
- Volunteers
- 29 people
- Sponsor
- Yale University
Gambling, Pathological, Anger
A Randomized Control Trial Examining Two Treatments for Problem Gambling
Despite evidence of high rates of concurrent substance use and anger problems among problem gamblers, until recently there have been no empirically evaluated treatments for these co-morbid problems.
- Trial name
- NCT00345527
- Testing
- Emotion and Behaviour Regulation Treatment (EBRT), Cognitive Behavioural Therapy
- Sponsor
- Centre for Addiction and Mental Health
Pathological Gambling
Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling
The purpose of this research study is to evaluate the efficacy (effectiveness) and safety of olanzapine in treating pathological gambling.
- Trial name
- NCT00438776
- Testing
- olanzapine, sugar pill
- Where
- United States
- Volunteers
- 42 people
- Sponsor
- Lindner Center of HOPE
Pathological Gambling, Obsessive Compulsive Disorder
Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD)
This study will explore the brain processes associated with inhibition and reward processing in pathological gamblers and people with obsessive compulsive disorder compared to healthy controls.
- Trial name
- NCT00211822
- Testing
- fMRI
- Where
- United States
- Volunteers
- 57 people, healthy volunteers welcome
- Sponsor
- Icahn School of Medicine at Mount Sinai
Pathological Gambling
Effects of Internet-based Treatment of Pathological Gambling
A trial testing the outcome of an Internet-based treatment of pathological gambling with the hypothesis that there will be improvements both immediately and up to 36 months.
- Trial name
- NCT01381250
- Testing
- cognitive behavior therapy
- Where
- Sweden
- Volunteers
- 284 people
- Sponsor
- Umeå University
Pathological Gambling
Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling
Pathological gambling (PG) is characterized by a persistent pattern of continued gambling behavior despite its adverse consequences.
- Trial name
- NCT01154712
- Testing
- Real Deep TMS
- Where
- Israel
- Volunteers
- 40 people
- Sponsor
- BeerYaakov Mental Health Center
Pathological Gambling
Cognitive Behavioral Therapy for Pathological Gambling
The purpose of the study is to evaluate a new form of counseling for pathological gambling and to see if the counseling is more effective than attending Gamblers Anonymous.
- Trial name
- NCT00337753
- Testing
- Cognitive Behavioral Therapy, Wait-list
- Where
- United States
- Volunteers
- 76 people
- Sponsor
- University of Minnesota
Pathological Gambling
Minimal and Brief Treatments for Pathological Gamblers
The purpose of the study is to examine whether problem gamblers who receive therapy calls in addition to a self-help manual will be more likely to quit or cut back on their gambling when compared with problem gamblers who receive…
- Trial name
- NCT00203645
- Testing
- Self-help treatment
- Where
- Canada
- Volunteers
- 312 people
- Sponsor
- University of Calgary
Pathological Gambling
Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling
The purpose of this study is to determine if nalmefene is safe and effective in the treatment of pathological gambling.
- Trial name
- NCT00132119
- Testing
- nalmefene HCl
- Volunteers
- 233 people
- Sponsor
- Somaxon Pharmaceuticals
Pathological Gambling
An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling
After completing all screening evaluations, subjects will receive unblinded N-Acetyl Cysteine 600 mg/day for 2 weeks. The dose will be raised to 1200 mg/day at visit 4 and to 1800 mg/day at visit 6 unless clinical improvement has…
- Trial name
- NCT00273702
- Testing
- N-Acetyl Cysteine
- Where
- United States
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- University of Minnesota
Concurrent Alcohol Dependence and Pathological Gambling
Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling
This study assessed whether naltrexone, an opioid antagonist, might be effective in reducing excessive gambling behavior in people who also drink heavily.
- Trial name
- NCT00326807
- Testing
- Naltrexone
- Where
- 2 sites in Canada, Finland
- Volunteers
- 50 people
- Sponsor
- Centre for Addiction and Mental Health